Indianapolis, IN, United States of America

Joan E Glusman

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joan E Glusman. Retrieved from https://idiyas.com/inventor/joan-e-glusman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joan E Glusman: Innovator in Breast Cancer Prevention

Introduction

Joan E Glusman is a notable inventor based in Indianapolis, IN (US). She has made significant contributions to the field of medical research, particularly in the area of breast cancer prevention. Her innovative approach has led to the development of a unique method aimed at reducing the risk of this prevalent disease.

Latest Patents

Joan E Glusman holds 1 patent for her invention titled "Methods of preventing breast cancer." This patent describes a method that involves administering an effective amount of a specific compound to individuals at risk, thereby providing a proactive approach to breast cancer prevention.

Career Highlights

Throughout her career, Glusman has been associated with Eli Lilly and Company, a leading pharmaceutical firm. Her work at Eli Lilly has allowed her to focus on groundbreaking research and development in the medical field, contributing to advancements that can potentially save lives.

Collaborations

Joan has collaborated with esteemed colleagues such as Robert S Eckert and Teri J Scott. These partnerships have fostered an environment of innovation and shared knowledge, enhancing the impact of their collective research efforts.

Conclusion

Joan E Glusman stands out as a pioneering inventor in the realm of breast cancer prevention. Her dedication to research and collaboration has the potential to make a lasting impact on public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…